NEW YORK (Reuters Health) May 08 - Since free antiretroviral therapy was offered to more than 80,000 HIV-infected adults in Malawi a few years ago, mortality has fallen by up to 35%, according to a report in the May 10th issue of The Lancet.

Read the rest of this entry »

NEW YORK (Reuters Health) May 09 - Patients who have undergone chemotherapy for AIDS-related non-Hodgkin’s lymphoma (NHL) along with concomitant highly active antiretroviral therapy (HAART) do not experience prolonged suppression of immune function, according to UK researchers.

Read the rest of this entry »

CHENNAI, India (Reuters Health) May 09 - Rapid oral-fluid testing for HIV, counseling, and mother-to-child transmission (MTCT) prophylaxis in all women at the time of delivery are feasible and cost-effective in resource-poor settings, according to the results of a study from India.

Read the rest of this entry »

NEW YORK (Reuters Health) May 13 - HIV-positive individuals with rheumatic disease can be effectively treated with anti-tumor necrosis factor (TNF) agents, according to a report in the May issue of the Annals of the Rheumatic Diseases.

Read the rest of this entry »

NEW YORK (Reuters Health) May 19 - Several types of non-AIDS-defining cancers occur more frequently among HIV-infected individuals - particularly anal cancer - than in the general population, investigators report in the Annals of Internal Medicine for May 20th.

Read the rest of this entry »

GRAZ, Austria (Reuters Health) May 20 - A scoring scale based on readily available clinical information can help diagnose tuberculosis in HIV-positive children in rural areas, researchers from Rwanda reported recently at the annual meeting of the European Society for Paediatric Infectious Diseases held in Graz, Austria.

Read the rest of this entry »

NEW YORK (Reuters Health) May 30 - Most primary HIV-1 infections result from transmission of single virus lineages that are able to avoid the immune system, according to a report in the May 19th issue of PNAS Early Edition.

Read the rest of this entry »

NEW YORK (Reuters Health) Jun 02 - As of the end of 2007, close to 3 million HIV-infected individuals in low- and middle-income nations had access to antiretroviral drug therapy (ART), representing an increase of nearly 950,000 people who received ART last year.

Read the rest of this entry »

June 2, 2008 (Bethesda, Maryland) — Discussions at last week’s National Institute of AIDS and Infectious Diseases (NIAID) AIDS Vaccine Research Subcommittee (AVRS) meeting may have substantial implications for the next HIV vaccine trial, on hold since last fall. It is likely to move forward with substantial changes in the scientific questions asked, the endpoints measured, and the number and type of participants.

Read the rest of this entry »

NEW YORK (Reuters Health) Jun 04 - In infants born to HIV-infected mothers, extended prophylaxis with nevirapine alone or combined with zidovudine for the first 14 weeks of life reduces their acquisition of HIV via breastfeeding, according to the results of a study conducted in Blantyre, Malawi.

Read the rest of this entry »